What is Aurinia Pharmaceuticals's revenue?

Aurinia Pharmaceuticals (AUPH) generated $298.3M in revenue over the trailing twelve months, up 20.6% year over year.

Is Aurinia Pharmaceuticals profitable?

Aurinia Pharmaceuticals reported $298.2M in net income over the trailing twelve months, a 100.0% net margin.

What are Aurinia Pharmaceuticals's profit margins?

Gross margin is 89.7% and operating margin is 41.7%, with a 100.0% net margin.

What is Aurinia Pharmaceuticals's earnings per share?

Aurinia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.17.

Where does Aurinia Pharmaceuticals's income statement data come from?

Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Aurinia Pharmaceuticals AUPH Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$77.71M+24.4%	$77.11M+28.8%	$73.47M+8.4%	$70.01M+22.4%	$62.47M+24.2%
Total cost of revenue	$6.51M-24.1%	$8.8M+58.5%	$8.18M+35.5%	$7.12M-20.1%	$8.57M+10.6%
Gross profit	$71.2M+32.1%	$68.32M+25.8%	$65.29M+5.8%	$62.89M+30.3%	$53.89M+26.7%
Gross margin	91.6%+5.4pp	88.6%-2.1pp	88.9%-2.2pp	89.8%+5.4pp	86.3%+1.7pp
Research and development	$7.47M+30.1%	$10.9M+34.4%	$8.44M+177%	$7.43M+82.2%	$5.74M+3.5%
General and administrative	$22.03M+8.3%	$29.26M-21.0%	$26.18M-38.2%	$26.02M-42.1%	$20.34M-57.4%
Total costs & expenses	$36.28M-10.7%	$43.88M-28.7%	$43.72M-22.0%	$49.93M-15.0%	$40.62M-36.1%
Operating income	$41.42M+89.6%	$33.24M+2,092%	$29.75M+153%	$20.08M+1,427%	$21.85M+265%
Operating margin	53.3%+18.3pp	43.1%+45.9pp	40.5%+23.2pp	28.7%+31.3pp	35%+61.3pp
Interest expense	$1.01M-5.2%	$1.05M-8.6%	$1.1M-9.0%	$1.12M-6.8%	$1.07M-16.8%
Income before income taxes	$43.93M+80.4%	$35.69M+2,943%	$31.96M+116%	$22.16M+1,399%	$24.35M+343%
Income tax expense	$9.57M+852%	-$175.1M—	$411K-10.1%	$643K-14.9%	$1.01M+36.0%
Net income	$34.36M+47.2%	$210.79M+14,651%	$31.55M+120%	$21.51M+2,880%	$23.34M+317%
Net margin	44.2%+6.8pp	273.4%+271pp	42.9%+21.8pp	30.7%+29.5pp	37.4%+58.7pp
Diluted earnings per share	$0.25+56.3%	$1.53+15,200%	$0.23+130%	$0.16+1,500%	$0.16+329%
EBITDA	$46.24M+73.2%	$38.1M+1,093%	$34.61M+108%	$24.95M+649%	$26.7M+418%
EBITDA margin	59.5%+16.8pp	49.4%+44.1pp	47.1%+22.6pp	35.6%+29.8pp	42.7%+59.5pp
EBIT	$41.42M+89.6%	$33.24M+2,092%	$29.75M+153%	$20.08M+1,427%	$21.85M+265%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Aurinia Pharmaceuticals.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's revenue?: Aurinia Pharmaceuticals (AUPH) generated $298.3M in revenue over the trailing twelve months, up 20.6% year over year.
Is Aurinia Pharmaceuticals profitable?: Aurinia Pharmaceuticals reported $298.2M in net income over the trailing twelve months, a 100.0% net margin.
What are Aurinia Pharmaceuticals's profit margins?: Gross margin is 89.7% and operating margin is 41.7%, with a 100.0% net margin.
What is Aurinia Pharmaceuticals's earnings per share?: Aurinia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.17.
Where does Aurinia Pharmaceuticals's income statement data come from?: Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.